Product Code: ETC070004 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The contract cell and gene therapy manufacturing market in Thailand has been experiencing remarkable growth in recent years. Cell and gene therapies are cutting-edge medical interventions that hold immense promise for treating various genetic and chronic diseases. Contract manufacturing organizations (CMOs) in Thailand play a critical role in supporting the development and production of these therapies for biopharmaceutical companies and research institutions. With an increasing number of cell and gene therapy products entering clinical trials and gaining regulatory approvals, the demand for specialized and scalable manufacturing services has risen in the Thailand market.
Several factors drive the growth of the contract cell and gene therapy manufacturing market in Thailand. Firstly, the rising prevalence of genetic disorders and chronic diseases in the country has fueled the need for advanced and personalized therapies, driving biopharmaceutical companies to outsource manufacturing to specialized CMOs. Secondly, Thailand robust infrastructure, skilled workforce, and favorable regulatory environment have attracted both domestic and international investors to establish cell and gene therapy manufacturing facilities in the country. Additionally, collaborations between CMOs and academic/research institutions have facilitated technology transfer and knowledge exchange, further promoting market growth.
Despite its potential, the contract cell and gene therapy manufacturing market in Thailand face certain challenges. One of the primary challenges is the complex and costly manufacturing process of cell and gene therapies. Ensuring compliance with stringent quality standards and regulatory requirements adds to the manufacturing complexity, making it essential for CMOs to invest in advanced technologies and skilled personnel. Additionally, the scarcity of experienced professionals in cell and gene therapy manufacturing can pose a human resource challenge for companies seeking to expand their operations in Thailand.
The Covid-19 pandemic has had a mixed impact on the contract cell and gene therapy manufacturing market in Thailand. While the pandemic disrupted supply chains and delayed some clinical trials, it also highlighted the significance of biopharmaceutical manufacturing capabilities in the country. The pandemic emphasized the need for domestic manufacturing capacity to ensure a reliable supply of essential therapies during emergencies. As a result, the Thailand government and industry stakeholders are likely to focus on further strengthening the country`s manufacturing capabilities in the cell and gene therapy sector.
The contract cell and gene therapy manufacturing market in Thailand are supported by several key players, both local and international. Local CMOs like Biogenix Labs Co., Ltd. and Chulalongkorn University`s Cell Therapy Research Institute have been actively involved in providing cell and gene therapy manufacturing services to biopharmaceutical companies and research institutions in Thailand. At the same time, multinational companies like Catalent, Inc. and Lonza Group have established a presence in the market, leveraging their global experience and infrastructure to cater to the growing demand for contract manufacturing services. These key players are actively collaborating with biotech firms, research centers, and healthcare providers to support the development and commercialization of advanced cell and gene therapies in Thailand.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Contract Cell and Gene Therapy Manufacturing Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Thailand Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Thailand Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2021 & 2031F |
3.6 Thailand Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Thailand Contract Cell and Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Contract Cell and Gene Therapy Manufacturing Market Trends |
6 Thailand Contract Cell and Gene Therapy Manufacturing Market, By Types |
6.1 Thailand Contract Cell and Gene Therapy Manufacturing Market, By Vector |
6.1.1 Overview and Analysis |
6.1.2 Thailand Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Vector, 2021-2031F |
6.1.3 Thailand Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2021-2031F |
6.1.4 Thailand Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2021-2031F |
6.2 Thailand Contract Cell and Gene Therapy Manufacturing Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Thailand Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2021-2031F |
6.2.3 Thailand Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2021-2031F |
6.2.4 Thailand Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Hepatological Diseases, 2021-2031F |
6.2.5 Thailand Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021-2031F |
7 Thailand Contract Cell and Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 Thailand Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries |
7.2 Thailand Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries |
8 Thailand Contract Cell and Gene Therapy Manufacturing Market Key Performance Indicators |
9 Thailand Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 Thailand Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2021 & 2031F |
9.2 Thailand Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Thailand Contract Cell and Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 Thailand Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Thailand Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |